An Investigator Initiated, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy of Humira (Adalimumab) For The Treatment of Interstitial Cystitis(IC).
Phase of Trial: Phase III
Latest Information Update: 20 Jul 2015
At a glance
- Drugs Adalimumab (Primary)
- Indications Interstitial cystitis
- Focus Registrational; Therapeutic Use
- 25 Aug 2013 Status changed from active, no longer recruiting to completed.
- 20 Jun 2013 Results published in the Journal of Urology.
- 11 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History